Labebet 200mg Tablet contains labetalol hydrochloride, a non-selective beta-adrenergic blocker with additional alpha-1 adrenergic blocking activity, used primarily in the management of hypertension. By antagonizing beta-1 and beta-2 receptors, labetalol reduces heart rate and myocardial contractility, leading to decreased cardiac output, while its alpha-1 blockade induces vasodilation, resulting in lowered peripheral vascular resistance. This dual mechanism effectively lowers blood pressure without causing significant reflex tachycardia. Labebet is indicated for the treatment of essential hypertension, including hypertensive emergencies and chronic hypertension, especially in patients who may benefit from combined alpha and beta blockade. The usual dosage should be individualized based on patient response, with careful titration to achieve optimal blood pressure control. Labebet 200mg Tablet is contraindicated in patients with bronchial asthma, severe bradycardia, heart block greater than first degree, cardiogenic shock, and decompensated cardiac failure. Caution is advised in patients with hepatic impairment, diabetes mellitus, and peripheral vascular disease. Common adverse effects include dizziness, fatigue, nausea, and hypotension. Labebet should be used under medical supervision with regular monitoring of blood pressure and heart rate to ensure safety and efficacy.